Literature DB >> 9171887

Regulatory elements of the mb-1 gene encoding the Ig-alpha component of the human B-cell antigen receptor.

I Leduc1, M Cogne.   

Abstract

The mb-1 gene encodes the Ig-alpha component of the B-cell antigen receptor. It is specifically expressed in pre-B and mature B cells but not in plasma cells losing membrane Ig (mIg) expression. We looked for transcriptional regulatory elements within a 12 kb genomic fragment. A strong promoter activity was found in a 591 bp fragment harboring consensus binding sites for known transcription factors including Ets, EBF/BlyF, LyF1/micro B and Spl. It was able to drive transcription of a reporter gene in the absence of any additional enhancer and was mostly active in B lymphocytes not in plasma cells or T cells. Although no fragment from the mb-1 gene displayed enhancer activity in combination with either the SV40, a Ig VH or a Ig VL promoter, a 1078 bp fragment corresponding to the 5' part of the gene behaved as a strong enhancer in either orientation in constructs driven by the mb-1 promoter itself. Deletions within this fragment allowed to delineate shorter sequences with enhancer activity upstream the first exon. The tissue-restricted, promoter-restricted and stage-specific activity of this 5' flanking region suggests that it is the main regulatory element of the mb-1 gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9171887     DOI: 10.1016/s0161-5890(96)00109-5

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

Review 1.  B cell-restricted human mb-1 gene: expression, function, and lineage infidelity.

Authors:  Bettie Herren; Peter D Burrows
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression.

Authors:  Anna Lagergren; Christina Manetopoulos; Håkan Axelson; Mikael Sigvardsson
Journal:  BMC Cancer       Date:  2004-11-15       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.